The company said it is evaluating its strategic options regarding ADX-097 as it shifts efforts over to pushing bempikibart.

If you haven’t found the right treatment for your alopecia areata yet, it may be right around the corner. There’s no cure for alopecia areata, but even with this condition, your hair follicles ...

WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...

Women also report feeling lower self-esteem and greater anxiety and depression after starting to lose their hair. Counseling can help if your hair loss affects your mental health.

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

For some people with alopecia areata, it does. It’s hard to predict. If your hair loss is mild, or less than 50%, you’re more likely to find an effective treatment that stops your immune ...

Alopecia refers to hair loss and can affect the scalp, eyebrows, eyelashes, and other areas of the body. There are different types of alopecia including an | Immunology ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...

The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.

Q32 Bio (Nasdaq: QTTB) has announced a corporate restructuring, shifting its focus entirely to the development of its lead ...